Vir Biotechnology, Inc. Other Current Assets
Vir Biotechnology, Inc. (VIR) had Other Current Assets of $100.00 thousand as of 2024-12-31, per its 10-K filed 2025-02-27.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:OtherAssetsCurrent · last filed 2025-02-27
- 2024-12-31: Other Assets, Current $100.00K.
- 2024-09-30: Other Assets, Current $0.00.
- 2024-06-30: Other Assets, Current $1.00M.
- 2024-03-31: Other Assets, Current $4.10M.
| Period end | Other Assets, Current |
|---|---|
| 2024-12-31 | $100.00K 10-K · filed 2025-02-27 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-04 |
| 2024-06-30 | $1.00M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $4.10M 10-Q · filed 2024-05-03 |
| 2023-12-31 | $7.60M 10-K · filed 2025-02-27 |
| 2023-09-30 | $4.80M 10-Q · filed 2023-11-03 |
| 2023-06-30 | $13.00M 10-Q · filed 2023-08-04 |
| 2023-03-31 | $17.90M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $26.40M 10-K · filed 2024-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |